We support the development of market access strategies that help our clients navigate the complexities of pricing, reimbursement, and payer engagement across diverse and evolving healthcare systems. Our end-to-end approach helps ensure your asset is well-positioned for market entry, is supported by the right evidence, delivers optimal value and is aligned with payer expectations to maximise patient access. For out-licensing, we help to strengthen your value proposition and pricing strategy, and support you with the tools and insights needed to engage potential partners effectively.
With broad experience across global markets, we bring together the strategic insight and practical know-how needed to guide your asset through the key stages of access planning and implementation. Our teams are tailored to your needs, offering a blend of advisory support and hands-on expertise across pricing, reimbursement, and access planning.
Maximise the value of your products with our bespoke solutions.
We work as a strategic partner to build tailored market access roadmaps that align with your asset’s development stage, target markets, and commercial objectives. Our support helps you anticipate key access challenges, make informed decisions early, and ensure a smooth path from development to reimbursement and launch.
tranScrip support the development of pricing strategies that balance payer expectations with commercial goals, while carefully managing international reference pricing (IRP) risks. By aligning launch sequencing with pricing strategy, we help you protect long-term value and secure sustainable market access.
We help you identify critical evidence gaps that may impact payer decisions and support the development of a strategic plan for real-world evidence (RWE) generation. This ensures that the right data is available at the right time to support value demonstration and reimbursement success.
We support the development of tailored value propositions and compelling messaging to engage payors and HTA bodies. We provide expert support across value dossier development, HTA submissions, and structured feedback responses. Through gap analysis and evidence strengthening, we ensure your data package meets stakeholder expectations and maximises the likelihood of market access success.
We design and execute targeted payer research to generate actionable insights that inform your market access, pricing, and evidence strategies. Our approach helps you understand payer perceptions, priorities, and potential barriers—ensuring your plans are grounded in real-world decision-making.
We deliver strategically structured, evidence-based materials to support engagement with payers and stakeholders From briefing decks to economic models and objection-handling guides, we ensure your teams are equipped with the right tools to communicate your asset’s value confidently and effectively.
Whether you’re building internal capabilities or already have an established team, we tailor our support to suit your needs and stage of development. We can operate as a fully embedded partner or provide focused, hands-on expertise to address specific gaps in strategy, resourcing, or insight. Our approach is flexible, collaborative, and responsive — offering the right level of guidance at each step.